ISMD2026 SCIENTIFIC PROGRAM, updated Mar 09 (download pdf)
FRIDAY, June 19 THURSDAY, June 18

08:30 - 10:00Molecular Detection of Bacteria
  Chairs: Andrea J. Grisold, Maria Elisabeth Mustafa
08:30From Culture to PCR: Is Molecular Diagnostics Ready to Take Over?
 Marc Lütgehetmann, UKE Hamburg, Germany
09:00Mycoplasmoides genitalium Macrolide Resistance:
Data from the University Hospital Graz
 Armin Hoffmann, Medical University of Graz, Austria
09:30Evaluation of a New Automated Assay for the Detection and Differentiation of Mycoplasma pneumoniae, Chlamydia pneumoniae and Legionella pneumophila
in respiratory samples
 Linda M. Bliem, Medical University of Graz, Austria
09:45Evaluation of a New Automated Bordetella species PCR with Focus on the Differentiation of B. pertussis and B. holmesii
 Eva Leitner, Medical University of Graz, Austria

10:00 - 10:30 Coffee Break / Industrial Exhibition / Poster View

10:30 - 12:00Quality Assurance - Quality Control
  Chairs: Christoph Buchta, Dietmar Enko
10:30IVDR in 2026 - Reasons and Proposals for the First Large Revision
 Duncan McPherson, QMD
11:00Legal Impact of the IVDR Revision on Laboratory Operators
 Karina E. Hellbert, Attorney at Law, Vienna, Austria
11:30Response to Emerging Diseases and the Role of EQA
 Oliver Donoso Mantke, QCMD, Glasgow, Scotland

12:00 - 13:30 Lunch Break / Industrial Exhibition / Poster View

13:30 - 15:00Noroviruses, Tropical Diseases
  Chairs: Hans-Joachim Burkardt, Evelyn Stelzl
13:30Norovirus Infections in Germany and Austria from a Molecular Epidemiological Perspective
  Sandra Niendorf, Robert Koch Institute, Berlin, Germany
14:00Norovirus Infections in Vulnerable Populations and Efficient Laboratory Testing
  Dieter Hoffmann, TUM, Munich, Germany
14:30A Rapid Diagnostic Approach to Tropical Fevers in Returning Travelers: The Potential of Modern Multiplex PCR
  Peter Starzengruber, Medical University of Vienna, Austria

15:00 - 15:30 Coffee Break / Industrial Exhibition / Poster View

15:30 - 17:00Oncology, Future Technologies
  Chairs: Alexander C. Haushofer, Hans Georg Mustafa
15:30Dysplasia Instead of HPV Testing: Incorporation of Biomarker Expression Profiling for Personalized Cervical Cancer Screening
 Andreas M. Kaufmann, Charité - Universitätsmedizin Berlin, Germany
16:00The Multifaceted Landscape of Circulating Tumor DNA Profiling
  Stefan Holdenrieder, TUM University Hospital Munich, Germany
16:30Label-Free Diagnostics for In Vivo and In Vitro Applications
  Oliver Hayden, TUM, Munich, Germany

IMPORTANT NOTE FOR AUSTRIAN PARTICIPANTS
WICHTIGE MITTEILUNG FÜR ÖSTERREICHISCHE TEILNEHMER/INNEN

17:00 Informationsveranstaltung zur Facharztprüfung aus Medizinischer und Chemischer Labordiagnostik für PrüfungskandidatInnen